| Literature DB >> 34946461 |
Georgios Afxonidis1, Dimitrios V Moysidis2,3, Andreas S Papazoglou3,4, Christos Tsagkaris5,6, Anna Loudovikou3,6, Georgios Tagarakis2,3, Georgios T Karapanagiotidis2,3, Ioannis A Alexiou2,3, Christophoros Foroulis2,3, Kyriakos Anastasiadis2,3.
Abstract
BACKGROUND: This randomized controlled trial aimed to investigate the influence of physical activity and respiratory physiotherapy on zero postoperative day on clinical, hemodynamic and respiratory parameters of patients undergoing cardiac surgeries under extracorporeal circulation.Entities:
Keywords: coronary artery bypass grafting; early mobilization; early physiotherapy; enhanced physiotherapy; open heart surgery; physiotherapy; randomized-controlled trial
Year: 2021 PMID: 34946461 PMCID: PMC8701754 DOI: 10.3390/healthcare9121735
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Flowchart of patient participation in this randomized controlled trial according to the CONSORT 2010 statement guidelines.
Baseline demographic and clinical characteristics of study participants.
| Variable | EEPC Group (n = 39) | CPC Group (n = 39) | |
|---|---|---|---|
| Age (years) | 63.5 ± 8.9 | 65.1 ± 8.9 | 0.424 |
| Male gender, n (%) | 34 (87.2%) | 31 (79.5%) | 0.362 |
| Body mass index (kg/m2) | 26.8 ± 4.2 | 27.9 ± 4.2 | 0.234 |
| Left Ventricular Ejection Fraction (%) | 50 ± 6 | 49.7 ± 6.5 | 0.856 |
| Type of surgery: | |||
| Coronary artery bypass graft, n (%) | 25 (64.1%) | 23 (59%) | |
| Aortic valve replacement, n (%) | 9 (23.1%) | 15 (38.5%) | |
| Mitral valve replacement, n (%) | 5 (12.8%) | 1 (2.5%) | 0.119 |
| Coronary artery grafts (number) | 3.1 ± 0.8 | 3 ± 0.8 | 0.593 |
| Red blood cells transfused (units) | 0.9 ± 0.9 | 0.5 ± 0.7 | 0.063 |
| Fresh frozen plasma transfused (units) | 1.9 ± 1.1 | 1.9 ± 1.2 | 0.772 |
| Cardiopulmonary bypass time (minutes) | 100.1 ± 21.3 | 99 ± 27.7 | 0.848 |
| Aortic cross-clamp time (minutes) | 68.5 ± 19.1 | 69.7 ± 19.5 | 0.770 |
Comparison of pre- and post-intervention laboratory, oxymetric and hemodynamic measurements.
| Variable | EEPC Group (n = 39) | CPC Group (n = 39) | ||
|---|---|---|---|---|
| Pre-intervention | 137.3 ± 2.6 | 139.1 ± 6.6 | 0.105 | 1.53 |
| Pre-intervention | 4.0 ± 0.4 | 4.0 ± 0.7 | 0.729 | 1.02 |
| Pre-intervention | 0.9 ± 0.3 | 0.9 ± 0.1 | 0.293 | 1.01 |
| Pre-intervention | 140.6 ± 25 | 153.5 ± 39.1 | 0.087 | 0.38 |
| Pre-intervention | 9.6 ± 0.98 | 9.6 ± 0.9 | 0.813 | 0.24 |
| Pre-intervention | 23.4 ± 2.7 | 24.3 ± 2.9 | 0.183 | 1.34 |
| Pre-intervention | 130.4 ± 14.2 | 127.1 ± 16 | 0.329 | −0.98 |
| Pre-intervention | 59.1 ± 8.5 | 63.9 ± 19.8 | 0.167 | 1.40 |
| Pre-intervention | 36.4 ± 2.3 | 36.8 ± 0.4 | 0.216 | 1.25 |
| Pre-intervention | 98.1 ± 1.9 | 99 ± 1.2 | 0.022 | 2.34 |
| Pre-intervention | 61.8 ± 6.8 | 58.4 ± 9 | 0.187 | −1.34 |
| Pre-intervention | 7.4 ± 0.03 | 7.4 ± 0.04 | 0.954 | 0.47 |
| Pre-intervention | 40.9 ± 4.3 | 40 ± 4 | 0.347 | −1.61 |
| Pre-intervention | 137.5 ± 63.8 | 149.4 ± 68.3 | 0.430 | 0.61 |
| Pre-intervention | 1.5 ± 0.6 | 1.6 ± 0.7 | 0.694 | 1.04 |
Figure 2Study protocol and main findings of this randomized-controlled trial.